share_log

Apollo Medical Hlgs Analyst Ratings

Benzinga ·  Oct 17, 2023 19:56
Date Upside/Downside Analyst Firm Price Target Change Rating Change Previous / Current Rating
10/17/2023 42.63% BTIG → $45 Initiates Coverage On → Buy
04/12/2023 39.46% B of A Securities → $44 Initiates Coverage On → Neutral
02/27/2023 90.17% Lake Street $40 → $60 Maintains Buy
12/19/2022 26.78% Lake Street → $40 Initiates Coverage On → Buy
09/21/2022 William Blair Initiates Coverage On → Outperform
08/08/2022 80.67% Barclays $50 → $57 Maintains Equal-Weight
08/12/2021 191.6% Barclays → $92 Initiates Coverage On → Equal-Weight

What is the target price for Apollo Medical Hlgs (AMEH)?

The latest price target for Apollo Medical Hlgs (NASDAQ: AMEH) was reported by BTIG on October 17, 2023. The analyst firm set a price target for $45.00 expecting AMEH to rise to within 12 months (a possible 42.63% upside). 4 analyst firms have reported ratings in the last year.

What is the most recent analyst rating for Apollo Medical Hlgs (AMEH)?

The latest analyst rating for Apollo Medical Hlgs (NASDAQ: AMEH) was provided by BTIG, and Apollo Medical Hlgs initiated their buy rating.

When is the next analyst rating going to be posted or updated for Apollo Medical Hlgs (AMEH)?

Analysts arrive at stock ratings after doing extensive research, which includes going through public financial statements, talking to executives and customers of Apollo Medical Hlgs, and listening in to earnings conference calls. Most analysts do this every three months, so you should get 4 ratings per company per firm each year. The last rating for Apollo Medical Hlgs was filed on October 17, 2023 so you should expect the next rating to be made available sometime around October 17, 2024.

Is the Analyst Rating Apollo Medical Hlgs (AMEH) correct?

While ratings are subjective and will change, the latest Apollo Medical Hlgs (AMEH) rating was a initiated with a price target of $0.00 to $45.00. The current price Apollo Medical Hlgs (AMEH) is trading at is $31.55, which is within the analyst's predicted range.

The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.
    Write a comment